Stocktoria

Kura Oncology, Inc. KURA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-11-05 · LEI

Kura Oncology, Inc. statistics & valuation

Market cap$967.6M
P / S14.3×
P / B5.6×
Net margin-412.9%
Return on equity-160.0%
FCF margin-104.8%
Net cash$139.4M
Enterprise value USD$828.3M
Earnings yield EBIT/EV-36.7%
Return on capital-48.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-322.90% -412.90% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-358.50% -449.90% 2016201720182019202020212022202320242025
Return on equity (%)
-48.50% -44.40% -37.50% -28.90% -14.70% -25.80% -32.30% -38.40% -42.10% -160.00% 2016201720182019202020212022202320242025
Shares outstanding
19.3M 29.4M 38.1M 45.4M 66.2M 66.6M 68.3M 74.3M 86.2M 87.9M 2016201720182019202020212022202320242025
Net debt ($)
-$2.4M -$4.3M -$8.6M -$18.9M -$321.2M -$42.6M -$28.0M -$214.9M -$139.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-39.50% -37.00% -33.10% -26.10% -13.80% -24.40% -29.80% -34.00% -22.90% -37.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
248.40% -104.80% 2016201720182019202020212022202320242025
Debt / equity (×)
0.13× 0.09× 0.05× 0.03× 0.01× 0.02× 0.02× 0.02× 0.06× 2016201720182019202020212022202320242025
EPS ($)
-$1.69 -$1.97 -$2.03 -$2.08 -$2.02 -$3.18 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-449.9%-358.5%————————
Net margin-412.9%-322.9%————————
FCF margin-104.8%248.4%————————
Return on assets-37.7%-22.9%-34.0%-29.8%-24.4%-13.8%-26.1%-33.1%-37.0%-39.5%
Return on equity-160.0%-42.1%-38.4%-32.3%-25.8%-14.7%-28.9%-37.5%-44.4%-48.5%
Debt / equity0.06×0.02×0.02×0.02×—0.01×0.03×0.05×0.09×0.13×
Current ratio6.069.4612.2618.5623.2624.4915.3913.319.4312.62

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.